- Home
- VRAX vs AMIX Comparison
VRAX vs AMIX Comparison
Compare VRAX & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- AMIX
- Stock Information
- Founded
- VRAX 2013
- AMIX 2014
- Country
- VRAX United Kingdom
- AMIX United States
- Employees
- VRAX N/A
- AMIX N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AMIX
- Sector
- VRAX Health Care
- AMIX
- Exchange
- VRAX Nasdaq
- AMIX NYSE
- Market Cap
- VRAX 17.2M
- AMIX 17.9M
- IPO Year
- VRAX 2022
- AMIX N/A
- Fundamental
- Price
- VRAX $2.80
- AMIX $0.79
- Analyst Decision
- VRAX
- AMIX
- Analyst Count
- VRAX 0
- AMIX 0
- Target Price
- VRAX N/A
- AMIX N/A
- AVG Volume (30 Days)
- VRAX 13.0M
- AMIX 609.9K
- Earning Date
- VRAX 11-06-2024
- AMIX 11-02-2024
- Dividend Yield
- VRAX N/A
- AMIX N/A
- EPS Growth
- VRAX N/A
- AMIX N/A
- EPS
- VRAX N/A
- AMIX N/A
- Revenue
- VRAX $156,419.00
- AMIX N/A
- Revenue This Year
- VRAX $5,169.18
- AMIX N/A
- Revenue Next Year
- VRAX $66.97
- AMIX N/A
- P/E Ratio
- VRAX N/A
- AMIX N/A
- Revenue Growth
- VRAX 1727.11
- AMIX N/A
- 52 Week Low
- VRAX $0.60
- AMIX $0.51
- 52 Week High
- VRAX $9.00
- AMIX $7.60
- Technical
- Relative Strength Index (RSI)
- VRAX 46.62
- AMIX N/A
- Support Level
- VRAX $2.40
- AMIX N/A
- Resistance Level
- VRAX $3.26
- AMIX N/A
- Average True Range (ATR)
- VRAX 0.75
- AMIX 0.00
- MACD
- VRAX -0.31
- AMIX 0.00
- Stochastic Oscillator
- VRAX 9.18
- AMIX 0.00
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.